GORD
5
0
0
1
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
6 treatments under study, led by Pantoprazole
Research Leaders
6 sponsors active, led by Takeda
Related Conditions
Often studied with 17 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
20.0%
1 terminated out of 5 trials
50.0%
-36.6% vs benchmark
40%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
The Bacterial Composition of the Stomach in Reflux Disease
Gastro-oesophageal Reflux and NeuroDisability (Cerebral Palsy) in CHILDren
Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)
vMII for Measurement of Oesophageal Bolus Transport and Reflux
On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
Research Network
Common Treatments
- Pantoprazole2
- Hellers Myotomy1
- No Intervention But Patients Are Undergoing An Upper Gi Endoscopy And Biopsies For Clinical Purposes1
- Domperidone Or Esomeprazole Conservative Management1
- Nissen Fundoplication1
Active Sponsors
- Takeda2
- Guy's and St Thomas' NHS Foundation Trust1
- UMC Utrecht1
- Imperial College London1
- British Society of Paediatric Gastroenterology, Hepatology and Nutrition1
Top Investigators
Honorary Consultant and Senior Lecturer
Julius Center for Health Sciences and Primary Care
Centre for Primary and Community Care, Sunderland, United Kingdom
University Hospitals Dorset NHS Foundation Trust
Related Conditions
- Gerd2
- Chronic Use Of Acid Suppressive Medication1
- Esophagitis1
- Achalasia1
- Gastric Cancer1